Lantheus Holdings (LNTH) Cash from Financing Activities (2014 - 2026)

Lantheus Holdings (LNTH) reported Cash from Financing Activities of -$11.6 million for Q1 2026, up 36.2% year-over-year from -$8.5 million in Q1 2025, and up 88.47% quarter-over-quarter from -$100.8 million in Q4 2025.

Lantheus Holdings (LNTH) Cash from Financing Activities (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Cash from Financing Activities data on file, last reported at -$11.6 million in Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at -$11.6 million, up 36.2% year-over-year; the trailing twelve-month figure through Mar 2026 was -$310.0 million (down 158.52% YoY), and the FY2025 annual result was -$316.6 million, down 167.08% from the prior year.
  • Cash from Financing Activities advanced to -$11.6 million in Q1 2026 per LNTH's latest filing, from -$100.8 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $317.8 million in Q4 2022 and troughed at -$103.7 million in Q4 2024.
  • A 5-year average of -$8.7 million and a median of -$4.1 million in 2023 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2022 and 2025: Cash from Financing Activities soared 15235.24% in 2022, then sank 99507.07% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $317.8 million in 2022, then plunged by 100.14% to -$450000.0 in 2023, then tumbled by 22935.33% to -$103.7 million in 2024, then rose by 2.77% to -$100.8 million in 2025, then soared by 88.47% to -$11.6 million in 2026.
  • Business Quant data shows LNTH's Cash from Financing Activities at -$11.6 million in Q1 2026, -$100.8 million in Q4 2025, and -$99.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 13.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 1.47 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -11.62 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -77.88 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn -18.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -11.62 Mn
Mar 31, 2026 -11.62 Mn
Dec 31, 2025 -100.79 Mn
Dec 31, 2025 -100.79 Mn
Sep 30, 2025 -99.17 Mn
Sep 30, 2025 -99.17 Mn
Jun 30, 2025 -98.41 Mn
Jun 30, 2025 -98.41 Mn
Mar 31, 2025 -18.22 Mn
Mar 31, 2025 -18.22 Mn
Dec 31, 2024 -103.66 Mn
Dec 31, 2024 -103.66 Mn
Sep 30, 2024 1.87 Mn
Sep 30, 2024 1.87 Mn
Jun 30, 2024 99,000.00
Jun 30, 2024 99,000.00
Mar 31, 2024 -16.85 Mn
Mar 31, 2024 -16.85 Mn
Dec 31, 2023 -450,000.00
Dec 31, 2023 -450,000.00